Detalhe da pesquisa
1.
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Hepatology
; 79(1): 39-48, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399238
2.
Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study.
J Hepatol
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527524
3.
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
J Hepatol
; 80(5): 730-743, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199298
4.
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases - An intention-to-treat analysis.
Liver Transpl
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619393
5.
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.
Hepatology
; 77(1): 20-32, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686937
6.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386786
7.
Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC.
Clin Gastroenterol Hepatol
; 21(6): 1552-1560.e2, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934287
8.
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Gastroenterology
; 163(6): 1630-1642.e3, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150526
9.
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis.
Hepatology
; 76(2): 303-316, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220609
10.
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.
Liver Int
; 43(7): 1497-1506, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157905
11.
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.
J Hepatol
; 77(6): 1545-1553, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777587
12.
Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions.
Semin Liver Dis
; 41(3): 409-420, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182588
13.
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
Am J Gastroenterol
; 116(7): 1514-1522, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941746
14.
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Am J Gastroenterol
; 115(7): 1066-1074, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618657
15.
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
Hepatology
; 70(3): 788-801, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30661255
16.
Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps.
Liver Int
; 40(2): 382-392, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823479
17.
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.
Clin Gastroenterol Hepatol
; 17(10): 2076-2084.e2, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30616022
18.
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.
Hepatology
; 67(5): 1920-1930, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29220537
19.
Autoimmune hepatitis: Current and future therapeutic options.
Liver Int
; 39(6): 1002-1013, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716203
20.
Accepting hepatitis C virus-infected donor hearts for transplantation: Multistep consent, unrealized opportunity, and the Stanford experience.
Clin Transplant
; 32(7): e13308, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869354